Repositioning Candidate Details

Candidate ID: R0849
Source ID: DB05685
Source Type: investigational
Compound Type: biotech
Compound Name: FX06
Synonyms: --
Molecular Formula: --
SMILES: --
DrugBank Description: FX06 is a naturally occurring peptide derived from the neo-N-terminus of fibrin (Bbeta(15-42)). It prevents leukocyte migration through the gap junctions of endothelial cells. FX06 has proven safe in acute and subchronic toxicological studies and recently entered clinical development. It is being developed by Fibrex Medical Inc.
CAS Number: --
Molecular Weight:
DrugBank Indication: Investigated for use/treatment in cardiac reperfusion injury and myocardial infarction.
DrugBank Pharmacology: --
DrugBank MoA: FX06 has a novel mechanism of action: it is a competitive inhibitor of the binding of fibrin E1 fragments to vascular endothelial (VE)-cadherin. Through this inhibition, it potently blocks the transmigration of inflammatory leukocytes through the endothelial barrier and prevents the downstream release of tissue-damaging mediators.
Targets: Cadherin-5
Inclusion Criteria: Therapeutic strategy associated